Pharma Giant Warns Pills Critical For Organ Transplant Patients' to Survive May Be Completely Empty in Urgent Recall

The logo of Japan's Astellas Pharma is seen at the company's headquarters in Tokyo. (Credit: YUICHI YAMAZAKI/AFP via Getty Images)

Astellas Pharma announced two urgent recalls for vital immunosuppressive drugs, Prograf and Astagraf XL, that are used to prevent organ rejection in transplant recipients.

The pharmaceutical company said some capsules in specific lots may be completely empty, posing a fatal risk to patients, reported the Daily Mail UK, who use these medications to maintain the delicate balance required to prevent the immune system from attacking transplanted organs.